| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 3.07e-11 | 114 | 179 | 13 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 9.00e-11 | 124 | 179 | 13 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 3.17e-10 | 137 | 179 | 13 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 1.98e-08 | 192 | 179 | 13 | GO:0008234 |
| GeneOntologyMolecularFunction | pantothenate kinase activity | 2.82e-06 | 4 | 179 | 3 | GO:0004594 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 6.99e-06 | 5 | 179 | 3 | GO:0140955 | |
| GeneOntologyMolecularFunction | bile acid:sodium symporter activity | 1.39e-05 | 6 | 179 | 3 | GO:0008508 | |
| GeneOntologyMolecularFunction | peptidase activity | USP53 USP18 USP30 USP45 USP11 USP9X USP43 RHBDL1 USP46 USP16 USP19 LACTB DPEP3 USP32 ADAMTS17 USP15 USP3 | 8.62e-05 | 654 | 179 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.90e-04 | 13 | 179 | 3 | GO:0046975 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.35e-04 | 34 | 179 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | superoxide dismutase copper chaperone activity | 2.38e-04 | 3 | 179 | 2 | GO:0016532 | |
| GeneOntologyMolecularFunction | ISG15-specific peptidase activity | 2.38e-04 | 3 | 179 | 2 | GO:0019785 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 2.98e-04 | 15 | 179 | 3 | GO:0140161 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP7A ABCB5 SLC2A14 SLC9B1P1 GRID2 SLC35E2B CCDC51 RYR1 TOMM70 SLC44A1 CATSPER1 SLC10A1 SLC10A2 CLCNKA SLC25A40 CLCNKB SLC22A13 SLCO1A2 SLC10A6 KCNMA1 SLC17A7 ATP2A3 SLC44A3 | 3.72e-04 | 1180 | 179 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.14e-04 | 70 | 179 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | acetyl-CoA binding | 4.74e-04 | 4 | 179 | 2 | GO:1905502 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 6.18e-04 | 19 | 179 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 7.22e-04 | 20 | 179 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 8.37e-04 | 21 | 179 | 3 | GO:1990380 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.06e-03 | 86 | 179 | 5 | GO:0004197 | |
| GeneOntologyMolecularFunction | histone H2A deubiquitinase activity | 1.17e-03 | 6 | 179 | 2 | GO:0140950 | |
| GeneOntologyMolecularFunction | transporter activity | ATP7A ABCB5 SLC2A14 SLC9B1P1 GRID2 SLC35E2B CCDC51 RYR1 TOMM70 SLC44A1 CATSPER1 SLC10A1 SLC10A2 CLCNKA SLC25A40 CLCNKB SLC22A13 SLCO1A2 SLC10A6 KCNMA1 SLC17A7 ATP2A3 SLC44A3 | 1.24e-03 | 1289 | 179 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.30e-03 | 90 | 179 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | copper chaperone activity | 1.63e-03 | 7 | 179 | 2 | GO:0016531 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 2.16e-03 | 8 | 179 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | histone deubiquitinase activity | 2.16e-03 | 8 | 179 | 2 | GO:0140934 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 2.16e-03 | 8 | 179 | 2 | GO:0140948 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP53 USP18 USP30 USP45 USP11 USP9X USP43 COPS3 USP46 USP16 USP19 USP32 USP15 USP3 | 3.53e-11 | 144 | 181 | 14 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 7.72e-11 | 125 | 181 | 13 | GO:0016579 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 DLG5 PRTG SEMA3C ATP7A ARHGEF28 MYO6 KIF26A GPR37 USP9X NTRK3 MPDZ REG1A GRID2 ADGRV1 ZDHHC17 IGFALS PTPRG MICALL2 PTPRZ1 CAPRIN2 DIAPH2 FUT9 FOXP1 STRC HERC1 CNTN1 STRCP1 | 7.56e-06 | 1285 | 181 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 IFT140 DLG5 PRTG SEMA3C ATP7A ARHGEF28 MYO6 KIF26A GPR37 USP9X NTRK3 MPDZ REG1A GRID2 ADGRV1 ZDHHC17 IGFALS PTPRG MICALL2 PTPRZ1 CAPRIN2 DIAPH2 KCNMA1 FUT9 FOXP1 STRC HERC1 CNTN1 STRCP1 | 1.13e-05 | 1463 | 181 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP53 UBR1 USP18 USP30 USP45 TRIM51 USP11 USP9X USP43 TRIM49D1 CUL9 COPS3 USP46 USP16 USP19 USP32 HERC1 ZBED1 USP15 HECTD1 USP3 NLRC3 LRRC41 | 2.67e-05 | 1009 | 181 | 23 | GO:0070647 |
| GeneOntologyBiologicalProcess | coenzyme A metabolic process | 5.31e-05 | 24 | 181 | 4 | GO:0015936 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP53 UBR1 USP18 USP30 USP45 TRIM51 USP11 USP9X USP43 TRIM49D1 CUL9 COPS3 USP46 USP16 USP19 USP32 HERC1 ZBED1 USP15 HECTD1 USP3 NLRC3 LRRC41 | 6.97e-05 | 1074 | 181 | 23 | GO:0043687 |
| GeneOntologyBiologicalProcess | monoubiquitinated protein deubiquitination | 7.62e-05 | 10 | 181 | 3 | GO:0035520 | |
| GeneOntologyBiologicalProcess | synapse assembly | EPHB3 DLG5 MYO6 USP9X NTRK3 GRID2 LRRC4 SETD5 CASKIN1 SRGAP2B CDH9 | 9.13e-05 | 308 | 181 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | coenzyme A biosynthetic process | 1.38e-04 | 12 | 181 | 3 | GO:0015937 | |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB3 DLG5 MYO6 USP9X NTRK3 MPDZ GRID2 LRRC4 CDH22 MICALL2 SETD5 CASKIN1 SRGAP2B CDH9 CDH10 | 1.56e-04 | 569 | 181 | 15 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of hippo signaling | 2.25e-04 | 14 | 181 | 3 | GO:0035332 | |
| GeneOntologyBiologicalProcess | cellular response to 2,3,7,8-tetrachlorodibenzodioxine | 2.28e-04 | 3 | 181 | 2 | GO:1904613 | |
| GeneOntologyBiologicalProcess | cerebellum development | 2.30e-04 | 139 | 181 | 7 | GO:0021549 | |
| Domain | USP_1 | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 7.03e-14 | 70 | 173 | 13 | PS00972 |
| Domain | UCH | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 8.54e-14 | 71 | 173 | 13 | PF00443 |
| Domain | USP_2 | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 8.54e-14 | 71 | 173 | 13 | PS00973 |
| Domain | USP_3 | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 1.03e-13 | 72 | 173 | 13 | PS50235 |
| Domain | USP_dom | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 1.03e-13 | 72 | 173 | 13 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 1.03e-13 | 72 | 173 | 13 | IPR001394 |
| Domain | USP_CS | USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 8.66e-13 | 66 | 173 | 12 | IPR018200 |
| Domain | Bilac:Na_transpt | 3.10e-06 | 4 | 173 | 3 | IPR004710 | |
| Domain | Ubiquitin_3 | 3.10e-06 | 4 | 173 | 3 | PF14836 | |
| Domain | Ub_USP-typ | 3.10e-06 | 4 | 173 | 3 | IPR028135 | |
| Domain | Type_II_PanK | 3.10e-06 | 4 | 173 | 3 | IPR004567 | |
| Domain | Fumble | 3.10e-06 | 4 | 173 | 3 | PF03630 | |
| Domain | DUSP | 1.53e-05 | 6 | 173 | 3 | PF06337 | |
| Domain | DUSP | 1.53e-05 | 6 | 173 | 3 | SM00695 | |
| Domain | SBF | 2.66e-05 | 7 | 173 | 3 | PF01758 | |
| Domain | DUSP | 2.66e-05 | 7 | 173 | 3 | PS51283 | |
| Domain | BilAc:Na_symport/Acr3 | 2.66e-05 | 7 | 173 | 3 | IPR002657 | |
| Domain | - | 2.66e-05 | 7 | 173 | 3 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 2.66e-05 | 7 | 173 | 3 | IPR006615 | |
| Domain | Transl_elong_EF1A_euk/arc | 8.53e-05 | 2 | 173 | 2 | IPR004539 | |
| Domain | Cl_channel-K | 8.53e-05 | 2 | 173 | 2 | IPR002250 | |
| Domain | USP7_C2 | 2.54e-04 | 3 | 173 | 2 | PF14533 | |
| Domain | USP_C | 2.54e-04 | 3 | 173 | 2 | IPR029346 | |
| Domain | Znf_UBP | 2.64e-04 | 14 | 173 | 3 | IPR001607 | |
| Domain | zf-UBP | 2.64e-04 | 14 | 173 | 3 | PF02148 | |
| Domain | ZF_UBP | 2.64e-04 | 14 | 173 | 3 | PS50271 | |
| Domain | HMA | 5.06e-04 | 4 | 173 | 2 | PF00403 | |
| Domain | HMA_2 | 5.06e-04 | 4 | 173 | 2 | PS50846 | |
| Domain | HMA_1 | 5.06e-04 | 4 | 173 | 2 | PS01047 | |
| Domain | - | 5.81e-04 | 73 | 173 | 5 | 2.60.120.260 | |
| Domain | fn3 | 7.93e-04 | 162 | 173 | 7 | PF00041 | |
| Domain | AWS | 8.38e-04 | 5 | 173 | 2 | SM00570 | |
| Domain | AWS | 8.38e-04 | 5 | 173 | 2 | PS51215 | |
| Domain | AWS_dom | 8.38e-04 | 5 | 173 | 2 | IPR006560 | |
| Domain | Choline_transpo | 8.38e-04 | 5 | 173 | 2 | PF04515 | |
| Domain | Choline_transptr-like | 8.38e-04 | 5 | 173 | 2 | IPR007603 | |
| Domain | Cadherin_C | 1.55e-03 | 25 | 173 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.55e-03 | 25 | 173 | 3 | IPR000233 | |
| Domain | FN3 | 1.71e-03 | 185 | 173 | 7 | SM00060 | |
| Domain | HMA_dom | 1.74e-03 | 7 | 173 | 2 | IPR006121 | |
| Domain | SUN_dom | 1.74e-03 | 7 | 173 | 2 | IPR012919 | |
| Domain | Sad1_UNC | 1.74e-03 | 7 | 173 | 2 | PF07738 | |
| Domain | Galactose-bd-like | 1.82e-03 | 94 | 173 | 5 | IPR008979 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 2.99e-05 | 7 | 136 | 3 | M27087 | |
| Pathway | REACTOME_COENZYME_A_BIOSYNTHESIS | 2.99e-05 | 7 | 136 | 3 | MM14765 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 9.72e-05 | 191 | 136 | 9 | MM15289 | |
| Pubmed | USP18 USP30 USP45 USP11 USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 5.91e-13 | 81 | 184 | 11 | 12838346 | |
| Pubmed | USP53 USP30 USP45 USP11 USP9X USP46 USP16 USP19 USP32 USP15 USP3 | 4.26e-10 | 147 | 184 | 11 | 29576527 | |
| Pubmed | Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin. | 1.99e-08 | 33 | 184 | 6 | 30323974 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP53 USP18 USP30 USP45 MYO6 USP11 USP43 MPDZ COPS3 USP46 BTBD9 USP16 USP19 POLR3A NMD3 PIK3C2A USP32 MMS19 USP15 HECTD1 USP3 KRT36 | 2.11e-08 | 1005 | 184 | 22 | 19615732 |
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 1.22e-07 | 23 | 184 | 5 | 14715245 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 17379144 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 17631502 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 23152917 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 22815849 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 2981478 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 20133774 | ||
| Pubmed | A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. | 5.80e-07 | 4 | 184 | 3 | 11479594 | |
| Pubmed | Identification of regulators of chaperone-mediated autophagy. | 5.80e-07 | 4 | 184 | 3 | 20797626 | |
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 9.89e-07 | 15 | 184 | 4 | 9827704 | |
| Pubmed | Photocaged Cell-Permeable Ubiquitin Probe for Temporal Profiling of Deubiquitinating Enzymes. | 1.17e-06 | 64 | 184 | 6 | 33141564 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.13e-06 | 212 | 184 | 9 | 33853758 | |
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 16541252 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 5.15e-06 | 22 | 184 | 4 | 26494785 | |
| Pubmed | USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. | 8.00e-06 | 8 | 184 | 3 | 22706160 | |
| Pubmed | UBR1 SEMA3C ARHGEF28 MPDZ ZDHHC17 POLR3A TOMM70 FREM2 CDC40 DIAPH2 YY1AP1 ZBED1 COG4 LRRC41 | 1.06e-05 | 650 | 184 | 14 | 38777146 | |
| Pubmed | MYO6 USP11 USP9X STAM USP16 USP19 LACTB USP32 HERC1 USP15 HECTD1 USP3 | 1.09e-05 | 481 | 184 | 12 | 28190767 | |
| Pubmed | 1.20e-05 | 9 | 184 | 3 | 23279374 | ||
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 1.62e-05 | 29 | 184 | 4 | 22036570 | |
| Pubmed | 1.70e-05 | 10 | 184 | 3 | 17329413 | ||
| Pubmed | DOCK3 PDE2A MYO6 USP11 USP9X ASH1L CUL9 NCAPH2 STAM LRRC4 USP16 EEF1A1 EEF1A2 FBN1 USP32 YY1AP1 ATM MERTK HECTD1 COG4 | 1.73e-05 | 1285 | 184 | 20 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 PDE2A KIF26A FBXL14 CUL9 CFAP43 SLC35E2B RYR1 TBC1D9 URB1 SETD5 CASKIN1 KANK3 DIAPH2 C3orf18 HERC1 HECTD1 ATP2A3 | 2.58e-05 | 1105 | 184 | 18 | 35748872 |
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 2.78e-05 | 2 | 184 | 2 | 27335120 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8812470 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 25919862 | ||
| Pubmed | Setd5, but not Setd2, is indispensable for retinal cell survival and proliferation. | 2.78e-05 | 2 | 184 | 2 | 36349512 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 18030470 | ||
| Pubmed | eEF1A demonstrates paralog specific effects on HIV-1 reverse transcription efficiency. | 2.78e-05 | 2 | 184 | 2 | 30782564 | |
| Pubmed | Isolation and characterization of the mouse ubiquitin-specific protease Usp15. | 2.78e-05 | 2 | 184 | 2 | 12532266 | |
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 2.78e-05 | 2 | 184 | 2 | 38069401 | |
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 2.78e-05 | 2 | 184 | 2 | 20805576 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 34910522 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 31726086 | ||
| Pubmed | Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2. | 2.78e-05 | 2 | 184 | 2 | 26002201 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 35741005 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 34768935 | ||
| Pubmed | The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders. | 2.78e-05 | 2 | 184 | 2 | 30370994 | |
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 2.78e-05 | 2 | 184 | 2 | 15044642 | |
| Pubmed | Common genetic variants on 5p14.1 associate with autism spectrum disorders. | 2.78e-05 | 2 | 184 | 2 | 19404256 | |
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 2.78e-05 | 2 | 184 | 2 | 8041726 | |
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 2.78e-05 | 2 | 184 | 2 | 18648499 | |
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 2.78e-05 | 2 | 184 | 2 | 8544406 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 26212729 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 21341987 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22846907 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24863058 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 2.78e-05 | 2 | 184 | 2 | 9916798 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 9916791 | ||
| Pubmed | Structural basis for a human glycosylation disorder caused by mutation of the COG4 gene. | 2.78e-05 | 2 | 184 | 2 | 19651599 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17825975 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19096717 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11687802 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22095224 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 38220433 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19636410 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17690477 | ||
| Pubmed | Feedback regulation of murine pantothenate kinase 3 by coenzyme A and coenzyme A thioesters. | 2.78e-05 | 2 | 184 | 2 | 16040613 | |
| Pubmed | A therapeutic approach to pantothenate kinase associated neurodegeneration. | 2.78e-05 | 2 | 184 | 2 | 30352999 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 7945283 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 32347192 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11014860 | ||
| Pubmed | 3.09e-05 | 12 | 184 | 3 | 22102170 | ||
| Pubmed | 4.01e-05 | 13 | 184 | 3 | 29285303 | ||
| Pubmed | NR2C2 DLG5 ATP7A MYO6 USP11 MPDZ ZDHHC17 USP16 LACTB EEF1A2 URB1 CAMKK2 GTF3C2 SLC25A40 PIK3C2A ATM DDX21 SUCO CLUH EDRF1 LRRC41 | 4.36e-05 | 1487 | 184 | 21 | 33957083 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 DLG5 KIF23 ARHGEF28 PANK3 NTRK3 USP43 MPDZ EEF1A1 EEF1A2 PANK2 PIK3C2A HECTD1 EDRF1 DOP1A | 5.92e-05 | 861 | 184 | 15 | 36931259 |
| Pubmed | 6.33e-05 | 15 | 184 | 3 | 8812466 | ||
| Pubmed | CUL9 ZDHHC17 USP19 MAP3K4 TOMM70 CAMKK2 SETD5 SPHKAP YY1AP1 USP15 | 6.78e-05 | 407 | 184 | 10 | 12693553 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MYO6 GPR37 USP9X COPS3 MAP3K4 USP32 ERCC6L2 DIAPH2 ATM HERC1 ATP2A3 | 7.49e-05 | 497 | 184 | 11 | 36774506 |
| Pubmed | Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional. | 8.32e-05 | 3 | 184 | 2 | 26013830 | |
| Pubmed | Barttin increases surface expression and changes current properties of ClC-K channels. | 8.32e-05 | 3 | 184 | 2 | 12111250 | |
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 8.32e-05 | 3 | 184 | 2 | 30801007 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 12399219 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 17329248 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 17510212 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 19559761 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 38952869 | ||
| Pubmed | Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11. | 8.32e-05 | 3 | 184 | 2 | 26503449 | |
| Pubmed | IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein. | 8.32e-05 | 3 | 184 | 2 | 17045569 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 11703943 | ||
| Pubmed | The amino-terminal domain of glutamate receptor delta2 triggers presynaptic differentiation. | 8.32e-05 | 3 | 184 | 2 | 19000899 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 7891151 | ||
| Pubmed | Barttin modulates trafficking and function of ClC-K channels. | 8.32e-05 | 3 | 184 | 2 | 16849430 | |
| Pubmed | Protein tyrosine phosphatase zeta/RPTPbeta interacts with PSD-95/SAP90 family. | 8.32e-05 | 3 | 184 | 2 | 10521598 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 37429391 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 28344757 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 18094726 | ||
| Pubmed | Structural variability of the ubiquitin specific protease DUSP-UBL double domains. | 8.32e-05 | 3 | 184 | 2 | 22001210 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 10982849 | ||
| Pubmed | Cadherins Interact With Synaptic Organizers to Promote Synaptic Differentiation. | 8.32e-05 | 3 | 184 | 2 | 29760652 | |
| Pubmed | Recent female mouse models displaying advanced reproductive aging. | 8.32e-05 | 3 | 184 | 2 | 16352410 | |
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 21969550 | ||
| Pubmed | 8.32e-05 | 3 | 184 | 2 | 18448518 | ||
| Pubmed | Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. | 8.32e-05 | 3 | 184 | 2 | 11734858 | |
| Pubmed | 9.38e-05 | 17 | 184 | 3 | 29299163 | ||
| Pubmed | MYO6 USP11 COPS3 STAM BTBD9 USP19 LACTB SLC25A40 HERC1 USP15 USP3 LRRC41 | 9.84e-05 | 604 | 184 | 12 | 38803224 | |
| Pubmed | USP53 IFT140 DLG5 KIF26A ADGRV1 SHISAL1 CAMKK2 GTF3C2 CASKIN1 CAPRIN2 ARHGAP20 | 1.30e-04 | 529 | 184 | 11 | 14621295 | |
| Cytoband | 16p13.3 | 6.25e-05 | 244 | 184 | 7 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 3.48e-04 | 426 | 184 | 8 | chr16p13 | |
| GeneFamily | Ubiquitin specific peptidases | USP53 USP18 USP30 USP45 USP11 USP9X USP43 USP46 USP16 USP19 USP32 USP15 USP3 | 1.08e-16 | 56 | 130 | 13 | 366 |
| GeneFamily | CD molecules|Type II classical cadherins | 9.86e-05 | 13 | 130 | 3 | 1186 | |
| GeneFamily | Solute carriers | SLC2A14 SLC35E2B SLC44A1 SLC10A1 SLC10A2 SLC25A40 SLC22A13 SLCO1A2 SLC10A6 SLC17A7 SLC44A3 | 1.34e-04 | 395 | 130 | 11 | 752 |
| GeneFamily | Fibronectin type III domain containing | 1.58e-04 | 160 | 130 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.65e-04 | 161 | 130 | 7 | 593 | |
| GeneFamily | Keratins, type I | 1.04e-03 | 28 | 130 | 3 | 608 | |
| GeneFamily | Components of oligomeric golgi complex | 1.40e-03 | 8 | 130 | 2 | 493 | |
| GeneFamily | Chloride voltage-gated channels | 2.22e-03 | 10 | 130 | 2 | 302 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | USP18 SEMA3C MYO6 GPR37 MPDZ PGM2L1 PPM1K TBC1D9 NMD3 EEF1A2 HMCN1 PTPRG FUT9 AHR FOXP1 ELF5 ATP2A3 CNTN1 | 9.33e-06 | 786 | 181 | 18 | M10961 |
| Coexpression | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP | 9.77e-06 | 20 | 181 | 4 | M1792 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP | 1.11e-05 | 200 | 181 | 9 | M8843 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON | 1.77e-05 | 8 | 181 | 3 | M4042 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | USP53 ADGRV1 HMCN1 CLCNKA CLCNKB RBFOX1 ADAMTS17 MERTK CNTN1 | 9.34e-08 | 188 | 184 | 9 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-07 | 190 | 184 | 9 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | DOCK3 ARHGEF28 USP43 ADGRV1 FREM2 PTPRZ1 ELF5 IQCJ-SCHIP1 SLC44A3 | 1.17e-07 | 193 | 184 | 9 | ab78fb1603ea6f720ba2d30148fe65dccf271fe1 |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 6.39e-07 | 173 | 184 | 8 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-06 | 185 | 184 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 185 | 184 | 8 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 187 | 184 | 8 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 189 | 184 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.24e-06 | 189 | 184 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 192 | 184 | 8 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 192 | 184 | 8 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.45e-06 | 193 | 184 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 197 | 184 | 8 | 22b26bac3a99b20c73bfa6e6f81026d064eaa9e8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.90e-06 | 200 | 184 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 160 | 184 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 160 | 184 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.10e-06 | 162 | 184 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.31e-06 | 163 | 184 | 7 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.99e-06 | 166 | 184 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-06 | 169 | 184 | 7 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-06 | 169 | 184 | 7 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 7.00e-06 | 170 | 184 | 7 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-06 | 171 | 184 | 7 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.27e-06 | 171 | 184 | 7 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.10e-06 | 177 | 184 | 7 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 183 | 184 | 7 | 262387ee8d43b96e5f1a77c75124459a506a6172 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 183 | 184 | 7 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 183 | 184 | 7 | c85a707acbcb582912e8ac080a36d05f91cfd7a2 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 184 | 184 | 7 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-05 | 186 | 184 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 189 | 184 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-05 | 191 | 184 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 192 | 184 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 192 | 184 | 7 | 39804d9ddc67c1b41887752df2503389eae44a1a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.54e-05 | 192 | 184 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 192 | 184 | 7 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 192 | 184 | 7 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 194 | 184 | 7 | acd5ba9a097595d4caab4f05440531c65a4aa7bc | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 194 | 184 | 7 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 194 | 184 | 7 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 194 | 184 | 7 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.71e-05 | 195 | 184 | 7 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.82e-05 | 197 | 184 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.82e-05 | 197 | 184 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 197 | 184 | 7 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.88e-05 | 198 | 184 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-05 | 198 | 184 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 199 | 184 | 7 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.01e-05 | 200 | 184 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.01e-05 | 200 | 184 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.01e-05 | 200 | 184 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.01e-05 | 200 | 184 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.01e-05 | 200 | 184 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.01e-05 | 200 | 184 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.01e-05 | 200 | 184 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.39e-05 | 154 | 184 | 6 | b16f3139ce50e70a6a2377b1da7d7877b4000ea1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-05 | 161 | 184 | 6 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.44e-05 | 165 | 184 | 6 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 6.44e-05 | 165 | 184 | 6 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.44e-05 | 165 | 184 | 6 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.44e-05 | 165 | 184 | 6 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 168 | 184 | 6 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-05 | 172 | 184 | 6 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.36e-05 | 173 | 184 | 6 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-05 | 174 | 184 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 9.19e-05 | 176 | 184 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.19e-05 | 176 | 184 | 6 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-05 | 177 | 184 | 6 | c274fbdc141855ff4581d437d4997c64cc193278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-05 | 177 | 184 | 6 | f5e6df5cafd003bbfbb3b634ee58d0b1e2be5cc7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-05 | 177 | 184 | 6 | c8a51e480b978dc0ded85583261f2c892e085be8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 179 | 184 | 6 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 180 | 184 | 6 | 25f8e82bbc1853cb7d072484e99369c72779dd1e | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 184 | 6 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 180 | 184 | 6 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 180 | 184 | 6 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.07e-04 | 181 | 184 | 6 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 184 | 6 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 181 | 184 | 6 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.07e-04 | 181 | 184 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 182 | 184 | 6 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 182 | 184 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-04 | 182 | 184 | 6 | 6e7dac78dc030f74e546b9f6db07556e9bb13ac2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 182 | 184 | 6 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 182 | 184 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-04 | 182 | 184 | 6 | cd972d30519db706477c6b0c901165b81b74abed | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 182 | 184 | 6 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 183 | 184 | 6 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 184 | 184 | 6 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 184 | 184 | 6 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 184 | 184 | 6 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.17e-04 | 184 | 184 | 6 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 185 | 184 | 6 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 185 | 184 | 6 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 185 | 184 | 6 | 110d5f02759c8235b14aea524ea47199696094ea | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-04 | 185 | 184 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-04 | 185 | 184 | 6 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 185 | 184 | 6 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 186 | 184 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| Drug | D-pantothenoyl-L-cysteine | 1.93e-06 | 4 | 180 | 3 | CID000440217 | |
| Drug | 17beta-estradiol glucuronide | 4.95e-06 | 32 | 180 | 5 | CID000066424 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 1.98e-07 | 3 | 173 | 3 | DOID:0080463 (implicated_via_orthology) | |
| Disease | pantothenate kinase-associated neurodegeneration (implicated_via_orthology) | 7.89e-07 | 4 | 173 | 3 | DOID:3981 (implicated_via_orthology) | |
| Disease | Bartter disease type 4B | 3.42e-05 | 2 | 173 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 3.42e-05 | 2 | 173 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 3.42e-05 | 2 | 173 | 2 | 613090 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 3.42e-05 | 2 | 173 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B | 3.42e-05 | 2 | 173 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 3.42e-05 | 2 | 173 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 3.42e-05 | 2 | 173 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 3.42e-05 | 2 | 173 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | Growth Disorders | 5.81e-05 | 36 | 173 | 4 | C0018273 | |
| Disease | Spermatogenic failure 7 | 1.02e-04 | 3 | 173 | 2 | cv:C2751811 | |
| Disease | SPERMATOGENIC FAILURE 7 | 1.02e-04 | 3 | 173 | 2 | 612997 | |
| Disease | Spermatogenic Failure 7 | 1.02e-04 | 3 | 173 | 2 | C2751811 | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 1.02e-04 | 3 | 173 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 2.03e-04 | 4 | 173 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 2.03e-04 | 4 | 173 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 2.24e-04 | 93 | 173 | 5 | C1535926 | |
| Disease | Leber Congenital Amaurosis | 2.81e-04 | 22 | 173 | 3 | C0339527 | |
| Disease | Pancreatic Neoplasm | 3.14e-04 | 100 | 173 | 5 | C0030297 | |
| Disease | severe acute respiratory syndrome, COVID-19 | ARHGEF28 USP9X EYS RBFOX1 RASGEF1B ADAMTS17 DIAPH2 KCNMA1 ZFHX3 IQCJ-SCHIP1 | 3.26e-04 | 447 | 173 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Aortic Rupture | 3.38e-04 | 5 | 173 | 2 | C0003496 | |
| Disease | Aortic Aneurysm, Ruptured | 3.38e-04 | 5 | 173 | 2 | C0741160 | |
| Disease | Malignant neoplasm of pancreas | 3.44e-04 | 102 | 173 | 5 | C0346647 | |
| Disease | Bartter syndrome | 5.05e-04 | 6 | 173 | 2 | cv:C0004775 | |
| Disease | Grand Mal Status Epilepticus | 6.56e-04 | 67 | 173 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 6.56e-04 | 67 | 173 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 6.56e-04 | 67 | 173 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 6.56e-04 | 67 | 173 | 4 | C0751523 | |
| Disease | Petit mal status | 6.56e-04 | 67 | 173 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 6.56e-04 | 67 | 173 | 4 | C0393734 | |
| Disease | Status Epilepticus | 6.94e-04 | 68 | 173 | 4 | C0038220 | |
| Disease | able to hear with hearing aids | 7.04e-04 | 7 | 173 | 2 | EFO_0009720 | |
| Disease | melanoma | 9.01e-04 | 126 | 173 | 5 | EFO_0000756 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 9.50e-04 | 33 | 173 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | triacylglycerol 58:10 measurement | 1.04e-03 | 34 | 173 | 3 | EFO_0010437 | |
| Disease | Congenital disorder of glycosylation | 1.44e-03 | 38 | 173 | 3 | cv:C0282577 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | response to glucocorticoid, osteonecrosis | 1.55e-03 | 39 | 173 | 3 | EFO_0004259, GO_0051384 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.84e-03 | 148 | 173 | 5 | C0279702 | |
| Disease | unipolar depression | TMEM150B SEMA3C PANK3 ASH1L PGBD1 SHISAL1 SLC10A2 PTPRG RBFOX1 RASGEF1B ZFHX3 DDX21 USP3 CDH9 CCS CNTN1 | 2.03e-03 | 1206 | 173 | 16 | EFO_0003761 |
| Disease | eye disease | 2.35e-03 | 45 | 173 | 3 | EFO_0003966 | |
| Disease | Hiatus hernia | 2.97e-03 | 14 | 173 | 2 | HP_0002036 | |
| Disease | Generalized seizures | 3.00e-03 | 101 | 173 | 4 | C0234533 | |
| Disease | Clonic Seizures | 3.00e-03 | 101 | 173 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 3.00e-03 | 101 | 173 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 3.00e-03 | 101 | 173 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 3.00e-03 | 101 | 173 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 3.00e-03 | 101 | 173 | 4 | C0751123 | |
| Disease | Complex partial seizures | 3.00e-03 | 101 | 173 | 4 | C0149958 | |
| Disease | Single Seizure | 3.00e-03 | 101 | 173 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 3.00e-03 | 101 | 173 | 4 | C3495874 | |
| Disease | Visual seizure | 3.00e-03 | 101 | 173 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 3.00e-03 | 101 | 173 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 3.00e-03 | 101 | 173 | 4 | C0422855 | |
| Disease | Gustatory seizure | 3.00e-03 | 101 | 173 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 3.00e-03 | 101 | 173 | 4 | C0422850 | |
| Disease | Olfactory seizure | 3.00e-03 | 101 | 173 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 3.00e-03 | 101 | 173 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 3.00e-03 | 101 | 173 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 3.00e-03 | 101 | 173 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 3.00e-03 | 101 | 173 | 4 | C4317109 | |
| Disease | Absence Seizures | 3.10e-03 | 102 | 173 | 4 | C4316903 | |
| Disease | Convulsions | 3.10e-03 | 102 | 173 | 4 | C4048158 | |
| Disease | Tonic Seizures | 3.10e-03 | 102 | 173 | 4 | C0270844 | |
| Disease | Retinitis Pigmentosa | 3.33e-03 | 104 | 173 | 4 | C0035334 | |
| Disease | Seizures, Focal | 3.33e-03 | 104 | 173 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 3.33e-03 | 104 | 173 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 3.33e-03 | 104 | 173 | 4 | C0494475 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 3.41e-03 | 15 | 173 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | C-X-C motif chemokine 10 measurement | 3.94e-03 | 109 | 173 | 4 | EFO_0008056 | |
| Disease | bacteriemia | 4.39e-03 | 17 | 173 | 2 | EFO_0003033 | |
| Disease | cocaine dependence | 4.82e-03 | 58 | 173 | 3 | EFO_0002610 | |
| Disease | parahippocampal gyrus volume measurement | 4.92e-03 | 18 | 173 | 2 | EFO_0010318 | |
| Disease | leukemia (implicated_via_orthology) | 5.47e-03 | 19 | 173 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | cutaneous melanoma | 5.70e-03 | 121 | 173 | 4 | EFO_0000389 | |
| Disease | sexual dimorphism measurement | DOCK3 PGBD1 FBN1 CATSPER1 PTPRG CASKIN1 DPEP3 KANK3 RASGEF1B ADAMTS17 ZFHX3 C3orf18 HERC1 SUCO | 5.77e-03 | 1106 | 173 | 14 | EFO_0021796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSAGMLCALTTLSQQ | 1356 | P23470 | |
| NAITIALSSCALFNM | 306 | Q96P26 | |
| QQQSLALNSSCMVQE | 601 | P35869 | |
| GSTGNICSVMLNVAT | 121 | Q96M42 | |
| CPLQAVVSMQAFQAA | 1856 | Q9NR48 | |
| LQCSNGIVGVMATNI | 61 | Q8NDM7 | |
| VVCLNTVMLVAQTFA | 456 | Q8NEC5 | |
| SVRQLSAQGQMTQLC | 11 | Q9UNS2 | |
| GMITFTCNLAENVSS | 96 | Q9H9E3 | |
| EMSDNLISGCLVQTN | 71 | Q2M3G0 | |
| NFTVLRNGSVDVTCM | 1021 | Q8WXG9 | |
| LTNVAVMNLSGNCLR | 361 | P35858 | |
| MQNFACSNVSQVQLI | 1036 | Q5JWR5 | |
| QVACMQFINALVTSP | 326 | O60879 | |
| NFNISGLQLCSMTQE | 91 | Q9UKW6 | |
| TIEMCNALNSVSENQ | 906 | Q93084 | |
| SANEQCQILFGMNAT | 471 | Q8TE56 | |
| INIDGMTCNSCVQSI | 381 | Q04656 | |
| TTDGINFMVNSQEIC | 296 | Q8N3J5 | |
| LFTLGLAQCAQVMSL | 426 | P49116 | |
| NSMLQSLVTLQLSFC | 156 | Q8NGA2 | |
| LGMAFVETSVKNNCN | 151 | Q8N4Z0 | |
| LNFVSGMQFLACISI | 121 | Q9NPB9 | |
| VAVKASQMGAVSQSC | 1286 | Q8N1W1 | |
| LNCVLSMIGNFTIIA | 31 | A6NIJ9 | |
| VGVVQLLLSSNMCAA | 161 | Q8WXD9 | |
| QLSSAEQLQGCQMEI | 291 | Q6A162 | |
| INLMNVSETSFVGCV | 101 | Q5T1H1 | |
| QSCLAQGLSTMLANL | 561 | Q12791 | |
| AGVAALMGALCTNQT | 821 | Q7RTR2 | |
| SAALVGQMCFQIGQA | 261 | Q14409 | |
| TLTCIAENVVGMSNA | 281 | Q16288 | |
| ALANYSIGVSCMNEI | 351 | Q12866 | |
| TLCGDIQLMLAQNAN | 746 | Q3B7T1 | |
| GNMVAQSSDVIAVCQ | 586 | Q96T76 | |
| QAQSEGISLQAMSCS | 296 | O76014 | |
| GTVCLQIQMERNTFT | 186 | A6NEK1 | |
| IICNMQSVGLNSTAL | 521 | P83111 | |
| SQELMVVCYTQQGTA | 1911 | Q5SZK8 | |
| TFDLTSCQAMFNIQG | 76 | Q9Y231 | |
| VSAAGSMLCQIVNSL | 1056 | Q15751 | |
| CLTQNNSTASTMGNL | 621 | Q8N187 | |
| AASVQAATSVQAMQG | 121 | Q9UK00 | |
| VNICNMTTSFRDGLA | 21 | Q8IY33 | |
| MNQGILALVSSIGCT | 86 | O43424 | |
| GNNSISFQSCMAQLF | 86 | Q6IF82 | |
| ISENNTISFNGCMTQ | 81 | A6NMZ5 | |
| QLLTFSAMCQNLART | 506 | O00443 | |
| CYINDLTVIQSTQGM | 81 | Q6PCE3 | |
| NSQMITFTFQNGCVA | 551 | Q6PCE3 | |
| LTSEDVQQLQSMLGC | 311 | O00408 | |
| CTPLNAALQASMAEN | 566 | Q9H334 | |
| GALSSICTQILAMVN | 1891 | Q8TDM6 | |
| VYTCMVTNVAGNSNA | 421 | Q9HBW1 | |
| LAFQDQGACMSLISV | 191 | P54753 | |
| NNGNDTCLLATMGLQ | 226 | P13473 | |
| TCLLATMGLQLNITQ | 231 | P13473 | |
| LSTVTIQAQQCLEGM | 216 | Q9ULI4 | |
| EIMQTCGNVSNQFQL | 146 | Q86WI0 | |
| NMSYVLQIVAICTNG | 381 | P23471 | |
| MFTAFQTCGNVAQTV | 21 | O43934 | |
| CFNIGNFNSLMAIIS | 296 | Q0VAM2 | |
| IQGMANIESLNLSGC | 86 | Q8N1E6 | |
| NSMLIVNLLAATGGC | 116 | Q8TDB8 | |
| QVMVTASGLQTAAAA | 561 | P14859 | |
| ILSQFNQNCITGSMS | 831 | Q9NY74 | |
| GMYLCVATNIAGNVT | 1146 | Q96RW7 | |
| TITNNIGSVARMCAV | 296 | Q9H999 | |
| AIYQCMAENSQGSIL | 391 | Q2VWP7 | |
| TITNNIGSIARMCAL | 496 | Q9BZ23 | |
| METGCQNVQLCSTIL | 256 | Q14973 | |
| NQCNTTRGNEVISVM | 141 | P05187 | |
| LLQMCTVSASNLGTA | 481 | Q9Y2V7 | |
| VFQMCNTLLQRNTET | 2731 | Q13315 | |
| MCSSGLVQALLTVLN | 911 | Q9ULT8 | |
| SVETCLNIGQMATTF | 161 | Q53HC5 | |
| CNIVTAYMATGVSQQ | 511 | O15354 | |
| NINLLSMCLNGVIDA | 1536 | Q8IZD9 | |
| SQGNMQSCSAEALLL | 591 | Q9Y6N8 | |
| SSSAAFQLQMLQIVC | 1021 | Q9P218 | |
| TEVLQNMCQIGSSNR | 2341 | P35555 | |
| NEVISAQQMSQIVSC | 281 | Q9H336 | |
| NMITGTSQADCAVLI | 101 | Q05639 | |
| NMITGTSQADCAVLI | 101 | P68104 | |
| ITVGENATMQCAASF | 516 | Q12860 | |
| NLNMTVQAAGVASCL | 171 | P35452 | |
| GNQGTLCTLEFAVQM | 6 | O14618 | |
| QSAALVGQMCFQIGQ | 266 | P32189 | |
| YQNLDMVVSSAIGCQ | 256 | Q9BRF8 | |
| QIQGTCNFMQESVLD | 626 | Q6IMN6 | |
| AQAIMVACTEGFSQS | 246 | O75578 | |
| NMITGTSQADCAVLI | 101 | Q5VTE0 | |
| VSITGMQDCVQLNQY | 151 | Q96RR4 | |
| MVATLLACGADVNAQ | 711 | Q6NY19 | |
| SNLTSSILAGCIQMV | 1116 | Q8IWT3 | |
| SEFILACQQMTVAGA | 396 | Q8WWI5 | |
| SEFILACQQMTIAGA | 391 | Q8N4M1 | |
| GTIQSCNTTAFVMAA | 606 | Q9UJ99 | |
| VGLFIENVQSLMAQC | 391 | Q9H069 | |
| TLSMGVLQCNLLANV | 321 | Q9H4B8 | |
| FNSTQDVNICLVSTM | 581 | Q5T890 | |
| NSNVGFVTMILQCSI | 631 | Q9NR30 | |
| ILNIQNVCMTFDVAS | 136 | Q96Q07 | |
| VVLAQCNFSLGQMVL | 226 | Q9Y226 | |
| GFFQSIQALMQTCSV | 3826 | P21817 | |
| NMQSCTAEALILSAG | 596 | Q9ULB4 | |
| QVAAMQVSPSLLNVC | 416 | Q96RY7 | |
| SQLAQMQCLISNVEA | 346 | O76013 | |
| QTQSKMITFAGCLTQ | 86 | O60412 | |
| ISCLMFLSQSQGQEA | 11 | P05451 | |
| EAGNINQSLMTLRTC | 356 | Q02241 | |
| RTVAFETGMQNTQLC | 256 | Q12908 | |
| ETGMQNTQLCSTIVQ | 261 | Q12908 | |
| TITNNIGSIARMCAL | 521 | Q8TE04 | |
| LCSQMTQLTASGNQT | 21 | Q8NGW6 | |
| AFQQSIEGLMTLCQE | 961 | Q9Y6R4 | |
| SNQMTAFNLAVCVAP | 501 | Q9P2F6 | |
| NAGATCYMNSVIQQL | 1561 | Q93008 | |
| GTVLLCQANQEGSSM | 226 | Q9NWB1 | |
| SALCGMTQVASAVAV | 556 | Q2M3C7 | |
| CSFNPNVNTVSVMIN | 166 | Q99985 | |
| MINNAIASLRNVCIS | 46 | A6NJY1 | |
| CRLVMAVDGINQFTS | 116 | P32745 | |
| IIACLSLITNNMVGA | 341 | Q8N4U5 | |
| QSCIFSQVLNMGAAL | 51 | A6NC51 | |
| LQQMLASCTGAILTS | 16 | Q8TBP6 | |
| QLTICNMLQGATELV | 166 | Q15345 | |
| CSQMAGVVQLVKSAA | 331 | Q96ER9 | |
| SSRLQSGMNLQICFV | 291 | P0DPB3 | |
| LACQSMDNQILIFGA | 476 | O60508 | |
| NISQMIACVGQQAIS | 791 | O14802 | |
| TELACNNTVIGSQMQ | 256 | Q9C0A6 | |
| MTSCGQQSLNVLAVL | 1 | Q3SXP7 | |
| MASQLCAQQPVQSEL | 351 | P0DMP2 | |
| LAVQFSCIEAVNMAS | 101 | Q9Y5N6 | |
| CNLGVAIVSMVNNST | 81 | Q9P2U7 | |
| SSNSFLCMENGTQIL | 126 | P46721 | |
| FLMTCENSSVVGINT | 406 | P46721 | |
| TSIGTGINMVFQNCS | 471 | P46721 | |
| GINMVFQNCSCIQTS | 476 | P46721 | |
| ASQFTLLVMQPCAGQ | 41 | O00287 | |
| LSSRLQSGMNLQICF | 366 | B3KU38 | |
| NLCGNSAQETVMSLS | 241 | Q96JS3 | |
| MLVALAQSNEQGQVC | 111 | O75783 | |
| CLFNTVMLQLVAAQG | 2171 | O60287 | |
| LAGGMSCEFLQQINS | 1191 | Q7RTU9 | |
| TTGMADCILVNSQFT | 166 | Q9H553 | |
| MNFIEAALLIQGSAC | 51 | Q6IBW4 | |
| CDSFVSQNMINVLNI | 296 | Q86WS4 | |
| VLMAVLAANAIAQSC | 501 | P51800 | |
| VLMAVLAANAIAQSC | 501 | P51801 | |
| CLTQQAVALQRTMNE | 1196 | O75153 | |
| NSELNLVGMICYTSQ | 286 | Q70EK8 | |
| NLGNTCFMNSVIQSL | 501 | O94966 | |
| FMNAVVQCLSNTDLL | 111 | Q70EL4 | |
| GITNLGNTCFFNAVM | 191 | Q70EL2 | |
| LGNTCFFNAVMQNLS | 201 | Q9Y5T5 | |
| SSLACNAECVMLQNV | 986 | O75970 | |
| MNSGILQVFQRALTC | 1 | Q9BSJ1 | |
| NIGYCQAMNIVTSVL | 596 | Q6ZT07 | |
| NNAMVLSACVQKSTA | 1111 | Q8IWV7 | |
| LSNLGNTCFMNSAIQ | 291 | Q9Y4E8 | |
| RTISLETGAQNIQMC | 256 | Q3KNW5 | |
| VAMQALTLLGACVSN | 61 | Q92783 | |
| TAVCILEGFQNQQSM | 211 | O94826 | |
| SAALSTNIMDCLQNV | 226 | P0CK96 | |
| QSISQMAGQSCVQLS | 716 | Q68DE3 | |
| NVTMANDSVVQCIVG | 1956 | Q86WI1 | |
| GSATNAILNMVNIAA | 496 | Q9UBS9 | |
| VKACMLSSNGFQNIS | 711 | Q9BYW2 | |
| CQMYQISCLGITTNE | 551 | Q8IUH5 | |
| QVMINQFVLAAGCAA | 11 | Q8IYN6 | |
| GCNMIQPVNAAVAQS | 616 | Q9H869 | |
| NTCFMNAILQSLSNI | 166 | Q9Y6I4 | |
| TVSNCMFISIALQSA | 216 | Q6ZNB5 | |
| GQTCCLNSLIQVFVM | 61 | Q3LFD5 | |
| IASICNMGTNASALE | 6 | P62068 | |
| MALLTQTQGSQSSQC | 156 | Q969J2 | |
| MNSGISQVFQRELTC | 1 | C9J1S8 | |
| VNLGNTCFMNSLLQG | 71 | Q70CQ3 | |
| TLAGGMSCEFLQQIN | 1191 | A6NGW2 | |
| QCVATLQVGSMQATD | 536 | Q8WUA4 | |
| GQTCCLNSLIQVFVM | 61 | Q9UMW8 | |
| NECGKTFVQNSSLVM | 451 | Q9NV72 | |
| ASVINNMLAEIFCQT | 541 | O96006 | |
| SVTYGATLCNMLAIQ | 211 | Q6PP77 | |
| LTNLGNTCFMNSALQ | 311 | P51784 | |
| LSNLGNTCFMNSSIQ | 736 | Q8NFA0 | |
| MAVALGCAIQASLNQ | 1 | Q6P9G9 | |
| QVMINQFVLTAGCAA | 11 | Q8TB05 | |
| SLCFFGQSVVNLQEM | 3486 | Q15911 | |
| EGAQILSQLQCSGMV | 681 | Q9UM54 | |
| GNMNQICVCIRVTSA | 266 | Q96D46 |